alliance/partnership

HEALTHPOINT, Ltd. Expands Reach to Greater China Region via Schmidt Scientific-Taiwan Licensing Agreement

Concerns: alliance/partnership
Released on: 25-Sep-2002

Type:

- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Preventive
- Technology

Therapeutic target:

- Dermatology
- Epidemiology
- Geriatrics
- Infectious Diseases
- Surgery

Concerns the following market:
- United States of America
- Hong Kong
- China
- Canada

Full Description:
(Fort Worth, TX, USA) - HEALTHPOINT, Ltd., a Texas-based market leader in infection prevention, tissue management, and dermatology products, has announced an international licensing agreement with Taipei-based Schmidt Scientific for Schmidt to manufacture and market HEALTHPOINT’s infection prevention products Triseptin® and Actiprep®. Based on HEALTHPOINT’s patented Trizenol® technology, a fast-acting and persistent topical antiseptic technology, the products are widely used in the U.S. in the fields of surgical scrubbing and patient preoperative prepping.

Schmidt, an international organization specializing in the sale and service of products and equipment for healthcare, will manufacture and market Triseptin, a brush-free surgical scrub, and Actiprep, a patient preoperative skin preparation, to medical institutions in the Greater China region.

The combined market for the products in Taiwan, Hong Kong, and People’s Republic of China is an estimated 1.23 billion people and nearly 70,000 hospitals.

Triseptin and Actiprep are composed of three key elements: a fast-acting, broad-spectrum antimicrobial active ingredient - ethyl alcohol; emollients with surfactants to condition the skin and remove dirt and organic debris; and a preservative system to help prolong the antimicrobial action of alcohol.

Both products are effective against multi-resistant microorganisms as well as viruses and gram negative and gram positive bacteria. The products have demonstrated superior efficacy and persistence in thorough in vivo studies in accordance with the U.S. FDA’s Tentative Final Monograph for Healthcare Antiseptic Drug Products for surgical scrubbing.

HEALTHPOINT, a DFB Pharmaceuticals, Inc. affiliate company, is based in Fort Worth, Texas, USA.

Schmidt Scientific Taiwan Ltd. (SST) is a distribution company that markets technology-based products in the medical and electronics fields. SST has operations in Taiwan and China.

  Contact for this news release: Jay Nisbet